Mode
Text Size
Log in / Sign up

ED-based cervical cancer screening finds elevated abnormal Pap rates and high-risk HPV in trial participantsED cervical cancer screening finds higher abnormal Pap rates than national average

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider ED screening identifies women with elevated abnormal Pap rates and HPV, but follow-up care coordination remains challenging.

This randomized controlled trial evaluated test results and subsequent care among 181 women ages 21-65 who received cervical cancer screening within 365 days after enrollment in an ED-based intervention trial. The study examined two ED-based screening interventions, though specific comparators were not reported. Secondary outcomes included HPV infection rates, Pap test results, cervical cancer diagnoses, and subsequent care procedures.

Main results showed 12% of screened women had abnormal Pap test findings, which was statistically significantly elevated compared to a national rate of 3.8% (Z = 5.55, p < 0.001). High-risk HPV infection was present in 15% of those tested, which was elevated compared to an estimated nationwide prevalence of 11% though this difference approached but did not reach statistical significance (Z = 1.63, p = 0.052). Notably, nearly half of patients who required colposcopy and biopsy procedures lacked a routine women's health provider.

Safety and tolerability data were not reported. Key limitations include lack of data on subsequent clinical care, which limits appreciation of ED-based screening efforts. The study also did not provide absolute numbers for abnormal findings and HPV infections, and comparisons to national rates are observational rather than from randomized comparisons. While ED-based screening interventions demonstrated meaningful positive impact on subsequent testing and care in this trial, causation from screening to reduced mortality was not directly demonstrated. The findings highlight both the potential of ED screening to identify at-risk women and the challenges in ensuring appropriate follow-up care.

Researchers looked at what happened after women received cervical cancer screening through an emergency department program. They studied 181 women ages 21 to 65 who got Pap tests and HPV tests after enrolling in a trial. The program was designed to offer screening to women who might not get it elsewhere.

The study found that 12% of women had abnormal Pap test results, which is significantly higher than the national average of 3.8%. About 15% tested positive for high-risk HPV infections. Nearly half of the women who needed follow-up procedures like colposcopy or biopsy reported not having a regular women's health provider.

This research shows that emergency department screening can identify women with abnormal results who might otherwise go undetected. However, the study only followed women for one year and didn't track whether finding these abnormalities actually prevented cancer or saved lives. The comparison to national rates isn't from a direct randomized comparison, so we can't be sure all the difference comes from the program itself.

Readers should understand this study demonstrates that emergency department screening can find women with abnormal cervical cancer tests. What we don't know yet is whether finding these abnormalities through emergency departments leads to better long-term health outcomes compared to other screening approaches.

What this means for you:
Emergency department cervical cancer screening found more abnormal results than national average, but long-term health benefits aren't yet known.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: More than 4300 lives are lost to cervical cancer in the US annually. The survival rate is nearly 100% when precancerous lesions are identified and acted upon appropriately. A randomized controlled trial of two Emergency Department-based (ED) cervical cancer screening interventions demonstrated that patients in each condition received screening at rates far above an untreated historical control group. While screening represents a necessary first step in preventing cervical cancer morbidity and mortality, a lack of data on subsequent clinical care limits appreciation of ED-based screening efforts. OBJECTIVE: The current study describes test results and subsequent care observed among patients who received documented cervical cancer screening following an ED-based intervention. METHODS: Information on HPV infections, Pap test results, and cervical cancer diagnoses documented in the electronic health record were collected from women ages 21-65 who were (a) enrolled into the above-mentioned trial and (b) received cervical cancer screening over the 365-days post enrollment. RESULTS: 181 women received screening. Of those who had a Pap test, 12% had abnormal findings. Compared to a national rate of 3.8%, significantly elevated risk was observed (Z = 5.55, p < 0.001). High-risk HPV infection was observed in 15% among those tested, elevated from an estimated nationwide prevalence of 11% (Z = 1.63, p = 0.052). Notably, nearly half of patients who went on to have colposcopy and cervical biopsy did not have a routine women's health provider. CONCLUSION: ED-based cervical cancer screening interventions have meaningful positive impact on subsequent testing and care.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.